Orange Book product · Generic (ANDA)
RESERPINE AND HYDROFLUMETHIAZIDE
HYDROFLUMETHIAZIDE; RESERPINE
At a glance
Sep 20, 1985
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 20, 1985
41 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROFLUMETHIAZIDE; RESERPINE
Strength
50MG;0.125MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 088907
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROFLUMETHIAZIDE; RESERPINE
- —SALUTENSINBrand (NDA)
NDA 012359 · SHIRE
- 1985RESERPINE AND HYDROFLUMETHIAZIDEGeneric (ANDA)
ANDA 088932 · IVAX PHARMS
- 1983HYDROFLUMETHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088195 · USL PHARMA
- 1983HYDROFLUMETHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088127 · WATSON LABS
- 1983HYDROFLUMETHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088110 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
